Quick Answer
Regenerative Medical Technology Group Inc. reported Operating Income of $81.2 thousand for fiscal year 2024.
Regenerative Medical Technology Group Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | $81.2K | +111.4% |
| 2023 | -$715.2K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$445.8K | -2368.7% | -78.2% |
| June 30, 2025 | -$250.1K | -16.9% | -285.3% |
| March 31, 2025 | $135.0K | +228.4% | +586.9% |
| September 30, 2024 | $19.6K | — | +109.2% |
| June 30, 2024 | -$214.0K | — | -103.6% |
| March 31, 2024 | -$105.1K | — | — |
- Regenerative Medical Technology Group Inc. showed an increase of +111.4% in Operating Income compared to the prior fiscal year.
- Over the 2023–2024 period, Regenerative Medical Technology Group Inc.’s operating income has grown by 111.4% (from -$715.2 thousand to $81.2 thousand).
- The most recent figure is from Regenerative Medical Technology Group Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: